Dl-Phenylalanine

Dl-Phenylalanine

SCHEMBL2939606

[2H]N[C@@H](Cc1ccccc1)C(=O)O

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SLC7A5 Q01650 3/20 0.74
▸ ALPI P09923 1/20 0.74
▸ PKM P14618 1/20 0.74
▸ PTGS1 P23219 1/20 0.74
▸ XIAP P98170 1/20 0.74
▸ SLC1A3 P43003 2/20 0.58
▸ SLC1A2 P43004 2/20 0.58
▸ SLC1A1 P43005 2/20 0.58
▸ CYP1A2 P05177 1/20 0.55
▸ SLC15A1 P46059 1/20 0.53
▸ SRR Q9GZT4 2/20 0.52
▸ LTA4H P09960 1/20 0.50
▸ CPA1 P15085 2/20 0.48
▸ CPA3 P15088 2/20 0.48
▸ FOLH1 Q04609 1/20 0.48
▸ CPB1 P15086 1/20 0.48
▸ CPB2 Q96IY4 1/20 0.48
▸ HDAC8 Q9BY41 1/20 0.47
▸ EPHX1 P07099 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dl-Phenylalanine SCHEMBL3439692 1.00 SLC7A5 (0.74) SLC7A5ALPIPKMPTGS1XIAP
Dl-Phenylalanine SCHEMBL1273725 0.88 SLC7A5 (0.74) SLC7A5ALPIPKMPTGS1XIAP
Phenylalanine Amide SCHEMBL16001480 0.86 ALPI (0.60) SLC7A5ALPIPKMPTGS1XIAP
Phenylalanine Amide SCHEMBL16001479 0.86 ALPI (0.60) SLC7A5ALPIPKMPTGS1XIAP
SCHEMBL23159186 0.85 SLC7A5 (1.00) SLC7A5ALPIPKMPTGS1XIAP
Dl-Phenylalanine SCHEMBL288606 0.85 SLC7A5 (1.00) SLC7A5ALPIPKMPTGS1XIAP
Dl-Phenylalanine SCHEMBL1330932 0.85 SLC7A5 (1.00) SLC7A5ALPIPKMPTGS1XIAP
Phenylalanine SCHEMBL8835931 0.85 SLC7A5 (1.00) SLC7A5ALPIPKMPTGS1XIAP
Phenylalanine SCHEMBL1449128 0.85 SLC7A5 (1.00) SLC7A5ALPIPKMPTGS1XIAP
Dl-Phenylalanine SCHEMBL2785094 0.85 SLC7A5 (1.00) SLC7A5ALPIPKMPTGS1XIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1699873-B1 COSMETIC APPLICATION OF ROD-COIL POLYMERS OREAL (FR) 2010-08-11 — — EP claimed
CN-115960111-A Antibody-drug conjugates 第一三共株式会社 2023-04-14 — — CN disclosed
CN-111183149-A Cytokine conjugates for the treatment of autoimmune diseases 辛索克斯公司 2020-05-19 — — CN disclosed
EP-3270701-B1 PROCESS FOR PRODUCING CREAMER COMPOSITIONS NESTEC SA (CH) 2019-01-02 — — EP disclosed
US-9257576-B2 Amino acid generator and polysiloxane composition containing the same NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2016-02-09 — — US disclosed
WO-2014205074-A2 DEVICES, COMPOSITIONS AND METHODS FOR IMAGING WITH RAMAN SCATTERING THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2014-12-24 — — WO disclosed
US-20110073977-A1 AMINO ACID GENERATOR AND POLYSILOXANE COMPOSITION CONTAINING THE SAME NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2011-03-31 — — US disclosed
EP-1699873-B1 COSMETIC APPLICATION OF ROD-COIL POLYMERS OREAL (FR) 2010-08-11 — — EP disclosed
CN-1795202-B Metal chelate complexes immobilized on solid supports for peptide preparation APLAGEN GMBH 2010-05-26 — — CN disclosed
EP-1699873-A1 COSMETIC APPLICATION OF ROD-COIL POLYMERS L'OREAL (FR) 2006-09-13 — — EP disclosed
CN-1795202-A Metal chelate complexes immobilized on solid supports for peptide preparation APLAGEN GMBH (DE) 2006-06-28 — — CN disclosed
WO-2005059032-A1 COSMETIC APPLICATION OF ROD-COIL POLYMERS L'OREAL (FR) 2005-06-30 — — WO disclosed
US-5424076-A Sustained release SCHWARZ PHARMA AG (DE) 1995-06-13 — — US disclosed
EP-0038758-B1 AMINO-ACIDS DERIVATIVES AND THEIR THERAPEUTIC USE SOCIETE CIVILE BIOPROJET (FR) 1985-03-06 — — EP disclosed
EP-0038758-A1 Amino-acids derivatives and their therapeutic use SOCIETE CIVILE BIOPROJET (FR) 1981-10-28 — — EP disclosed
EP-0028251-A1 PROCESS FOR PRODUCING N-ACYL-D-PHENYLALANINE ESTER. ETHYL CORP (US) 1981-05-13 — — EP disclosed
EP-0028251-A4 PROCESS FOR PRODUCING N-ACYL-D-PHENYLALANINE ESTER. ETHYL CORP (US) 1981-03-27 — — EP disclosed
WO-1980002421-A1 PROCESS FOR PRODUCING N-ACYL-D-PHENYLALANINE ESTER ETHYL CORP (US) 1980-11-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110073977-A1 AMINO ACID GENERATOR AND POLYSILOXANE COMPOSITION CONTAINING THE SAME DAO, BCAT1, BCAT2 SLC7A5 183/4885ALPI 4274/4885PKM 2510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback